Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 67Congress 0Executive branch 0Insiders 67
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · $250K+ · 67 trades

Trades
67
Buys 0 · Sells 67
People
20
Stocks
1
Disclosed value
$38.5M
range midpoints · Congress & executive
Filed late
13
  1. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  2. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  3. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  4. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  5. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  6. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  7. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  8. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  9. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  10. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  11. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  12. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  13. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  14. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  15. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  16. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  17. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  18. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  19. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  20. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  21. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  22. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  23. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  24. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$280Kdisclosed Aug 31 · filed 4 days after the trade
  25. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day